Appendectomy Versus Observation for Appendicitis in Neutropenic Children With Cancer.

Journal Article (Journal Article)

BACKGROUND: Optimal management of neutropenic appendicitis (NA) in children undergoing cancer therapy remains undefined. Management strategies include upfront appendectomy or initial nonoperative management. We aimed to characterize the effect of management strategy on complications and length of stay (LOS) and describe implications for chemotherapy delay or alteration. METHODS: Sites from the Pediatric Surgery Oncology Research Collaborative performed a retrospective review of children with NA over a 6-year period. RESULTS: Sixty-six children, with a median age of 11 years (range 1-17), were identified with NA while undergoing cancer treatment. The most common cancer diagnoses were leukemia (62%) and brain tumor (12%). Upfront appendectomy was performed in 41% of patients; the remainder had initial nonoperative management. Rates of abscess or perforation at diagnosis were equivalent in the groups (30% vs 24%; P = .23). Of patients who had initial nonoperative management, 46% (17 of 37) underwent delayed appendectomy during the same hospitalization. Delayed appendectomy was due to failure of initial nonoperative management in 65% (n = 11) and count recovery in 35% (n = 6). Cancer therapy was delayed in 35% (n = 23). Initial nonoperative management was associated with a delay in cancer treatment (46% vs. 22%, P = .05) and longer LOS (29 vs 12 days; P = .01). Patients who had initial nonoperative management and delayed appendectomy had a higher rate of postoperative complications (P < .01). CONCLUSIONS: In pediatric patients with NA from oncologic treatment, upfront appendectomy resulted in lower complication rates, reduced LOS, and fewer alterations in chemotherapy regimens compared to initial nonoperative management.

Full Text

Duke Authors

Cited Authors

  • Many, BT; Lautz, TB; Dobrozsi, S; Wilkinson, KH; Rossoff, J; Le-Nguyen, A; Dakhallah, N; Piche, N; Weinschenk, W; Cooke-Barker, J; Goodhue, C; Zamora, A; Kim, ES; Talbot, LJ; Quevedo, OG; Murphy, AJ; Commander, SJ; Tracy, ET; Short, SS; Meyers, RL; Rinehardt, HN; Aldrink, JH; Heaton, TE; Ortiz, MV; Baertschiger, R; Wong, KE; Lapidus-Krol, E; Butter, A; Davidson, J; Stark, R; Ramaraj, A; Malek, M; Mastropolo, R; Morgan, K; Murphy, JT; Janek, K; Le, HD; Dasgupta, R; Lal, DR; PEDIATRIC SURGICAL ONCOLOGY RESEARCH COLLABORATIVE,

Published Date

  • February 2021

Published In

Volume / Issue

  • 147 / 2

PubMed ID

  • 33504609

Electronic International Standard Serial Number (EISSN)

  • 1098-4275

Digital Object Identifier (DOI)

  • 10.1542/peds.2020-027797


  • eng

Conference Location

  • United States